Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
15.4%
% of HRTS's 39 holdings also in LFSC
19.4%
% of LFSC's 31 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus LFSC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in LFSC |
Overlap | |
|---|---|---|---|---|
 |
BRIDGEBIO PHARMA, INC. | 4.2% | 4.3% | 4.2% |
|
ULTRAGENYX PHARMACEUTICAL IN | 1.8% | 3.8% | 1.8% |
|
MADRIGAL PHARMACEUTICALS, INC. | 1.6% | 1.4% | 1.4% |
|
AKERO THERAPEUTICS, INC. | 1.3% | 2.6% | 1.3% |
|
SOLENO THERAPEUTICS INC | 0.9% | 4.4% | 0.9% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to LFSC
|
ELI LILLY & CO | 7.2% |
|
VERTEX PHARMACEUTICALS INC | 5.8% |
|
ALNYLAM PHARMACEUTICALS INC | 5.0% |
 |
NOVO NORDISK A/S-B | 3.9% |
|
CRINETICS PHARMACEUTICALS INC | 3.8% |
|
AMGEN INC | 3.8% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.7% |
 |
ASTRAZENECA PLC | 3.6% |
|
ASCENDIS PHARMA A/S | 3.5% |
|
CYTOKINETICS INC | 3.3% |
HRTS Underweight Relative to LFSC
|
RADNET INC | -8.8% |
|
INSMED INC | -6.0% |
|
INTRA-CELLULAR THERAPIES INC | -6.0% |
|
WAVE LIFE SCIENCES LTD. | -6.0% |
|
LIVANOVA PLC | -5.9% |
|
BLUEPRINT MEDICINES CORP. | -5.7% |
|
MERIT MEDICAL SYSTEMS INC | -5.3% |
|
NEOGENOMICS INC | -4.9% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -4.3% |
|
SAREPTA THERAPEUTICS INC | -4.1% |